mTOR inhibitors in renal cell carcinoma

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.4, 2011-07, pp. : 359-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rechallenge with mTOR Inhibitors in Metastatic Renal Cell Carcinoma Patients Who Progressed on Previous mTOR Inhibitor Therapy

Oncology, Vol. 85, Iss. 1, 2013-06 ,pp. : 8-13

Karger

Access to resources Recommend Favorite

Bullous pemphigoid induced by m‐TOR inhibitors in renal transplant recipients

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1626-1630

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 8, 2014-08 ,pp. : 847-856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunosuppressive minimization with mTOR inhibitors and belatacept

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 8, 2015-08 ,pp. : 921-927

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Development of mTOR Inhibitors: A Focus on Lymphoma

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 103-110

Bentham Science Publishers

Access to resources Recommend Favorite